GIRARDI THOMAS V 4
4 · Astex Pharmaceuticals, Inc · Filed May 21, 2013
Insider Transaction Report
Form 4
GIRARDI THOMAS V
Director
Transactions
- Exercise/Conversion
Director Stock Option (Right to buy)
2013-05-17−60,000→ 0 totalExercise: $4.03From: 2003-05-22Exp: 2013-05-22→ Common Stock (60,000 underlying) - Exercise/Conversion
Director Stock Option (Right to buy)
2013-05-17−7,500→ 0 totalExercise: $4.03Exp: 2013-05-22→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2013-05-17$4.03/sh+75,000$302,250→ 348,500 total
Footnotes (1)
- [F1]Option vested and became exercisable as to 1/4th of the shares on the May 22, 2003 grant date and on each three-month anniversary thereafter.